|Articles|July 6, 2016
Hanmi Selects Medidata Cloud Technology
Medidata has signed a multi-year deal with South Koreas Hanmi Pharmaceuticals.
Advertisement
Medidata has signed a multi-year deal with South Korea's Hanmi Pharmaceuticals. The Seoul-based company is adopting Medidatas Clinical Cloud platform into all clinical trials across its drug development programs.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief: De-Identified RWE Gains Ground, HHS Funding Stabilizes Research, and US Finalizes WHO Exit
2
What 2026 Will Demand From Clinical Operations: Rethinking Efficiency, Access, and AI
3
ACT Brief: Decentralized Innovation Faces Reality, RWE Finds Its Lane, and Clinical Ops Reset for 2026
4
ESG as a Quality System: Practical Steps to Embed Sustainability Into Vendor Oversight
5